Imperial College London

Imperial College London

A public research university with a focus on science, medicine, engineering, and business. It was founded in 1907 and is located in London, England.

Imperial College London is a London-based institute of higher education. It is a STEM-based university that offers educational programs for both undergraduate and postgraduate students and conducts research.

COVID-19

The college developed an RNA-based vaccine for COVID-19 during the pandemic. The vaccine was approved to be tested on animals where studies showed that the animals began producing antibodies that neutralized the virus after being given the vaccine. The college has received funding to continue developing the vaccine but has not been yet approved for human trials.

Timeline

People

Name
Role
LinkedIn

Professor Alice P. Gast

President

Further reading

Title
Author
Link
Type
Date

Coronavirus: Early signs outbreak 'slowing' in UK, says Imperial College professor

Richard Williams

Web

March 30, 2020

Fighting coronavirus: Imperial researchers secure funds to help tackle COVID-19 | Imperial News | Imperial College London

Ryan O'Hare

Web

March 23, 2020

Documentaries, videos and podcasts

Title
Date
Link

A day in the life of Imperial

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Michael Le Page, Clare Wilson, Jessica Hamzelou, Adam Vaughan, Conrad Quilty-Harper and Layal Liverpool
July 24, 2020
New Scientist
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Business Standard Editorial Comment
July 21, 2020
@bsindia
Problems along the LAC demand transparency
Chris Price
July 16, 2020
The Telegraph
Your evening guide: Russia accused of trying to hack Covid-19 research labs and Sir Patrick Vallance says UK 'outcome has not been good'
July 7, 2020
WebWire
Synthesis Institute BV ("Synthesis"), a leader in professional, medically-supervised psychedelic experiences, has closed a US$2.75 million round of funding led by Novamind Ventures. In the midst of the worldwide COVID-19 pandemic -- and a 20% spike in prescriptions for antidepressant and anti-anxiety drugs -- the seed funding will be used to further develop the company's scientist-backed, data-driven platform for psychedelic research, training and access to legal experiences. Numerous st...
By Ryan Morrison For Mailonline
June 29, 2020
Mail Online
Researchers from Imperial College London created mathematical models of the impact volcanic activity and a large asteroid would have on dinosaur habitats.
June 25, 2020
The Times of India
India News: LONDON: Human trials have begun this week of a second Covid-19 vaccine candidate in the UK -- this time created by Imperial College London -- just as th.
James Rogers
June 25, 2020
Fox News
The first volunteer in a U.K. trial has received an experimental coronavirus vaccine developed by researchers at Imperial College London.
Breakingnews.ie
June 23, 2020
Breaking News
Imperial's candidate is the second of the two potential vaccines being trialled in the UK.
Sidhant Mamtany
June 24, 2020
news.google.com
The first healthy volunteer has now received a coronavirus vaccine developed by Imperial College London researchers, the team behind the project said on Tuesday
June 23, 2020
LatestLY
Get latest articles and stories on World at LatestLY. The first healthy volunteer has now received a coronavirus vaccine developed by Imperial College London researchers, the team behind the project said on Tuesday. World News | First Volunteer Given UK's Imperial College COVID-19 Vaccine.
ANI
June 24, 2020
@bsindia
Imperial College Londons vaccine candidate is being developed and trialled with the help of more than £41 million in funding from the UK government and a further £5 million in philanthropic donations
June 24, 2020
NDTV.com
The first healthy volunteer has now received a coronavirus vaccine developed by Imperial College London researchers, the team behind the project said on Tuesday.
June 19, 2020
Tech2
The candidate was made using synthetic strands of genetic code (RNA) based on the virus's genetic material.
TRT World
June 16, 2020
Imperial College set to launch human trials of potential Covid-19 vaccine
The trials, partially funded by the UK, are the first human tests of a technology that researchers say could transform vaccine development by enabling rapid responses to emerging diseases such as the infection caused by the SARS-CoV-2.
Guardian staff and agencies
June 16, 2020
the Guardian
Professor Robin Shattock, left, and technician Leon Mcfarlane as the team at Imperial College in London continue to work on a Covid-19 vaccine. Photograph: Thomas Angus/Imperial College London/PA
Ben Adams
June 16, 2020
FierceBiotech
As the U.S., Germany and France start funneling more cash into their life sciences for a solution to the COVID-19 problem, the U.K. is following suit with a new type of vaccine.
June 8, 2020
The Times of India
Europe News: Wide-scale lockdowns including shop and school closures have reduced Covid-19 transmission rates in Europe enough to control its spread and may have a
Zee Media Bureau
June 4, 2020
Zee News
A new study has found that the asteroid which led to the extinction of dinosaurs hit Earth at the deadliest possible angle.
BioSpace
June 2, 2020
BioSpace
TRV027 is a novel AT 1 receptor selective agonist with the potential to treat acute lung injury and ARDS Robust clinical development history with well-characterized PK and demonstrated safety in ~700 individuals -- CHESTERBROOK, Pa., June 02, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced it ha
Jonathan Amos
May 26, 2020
BBC News
The angle at which a life-destroying space rock hit Earth 66 million years ago was particularly lethal.
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.